Failure rate: Why many cancer drugs don't receive FDA approval, and what can be done about it

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|121|10|1529-1530

ISSN: 0008-543x

Source: CANCER, Vol.121, Iss.10, 2015-05, pp. : 1529-1530

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content